Synlett 2010(10): 1536-1538  
DOI: 10.1055/s-0029-1219931
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of the Tetrahydropyran Subunit (C8-C20 Fragment) of (-)-Dactylolide and (-)-Zampanolide

Ch. Raji Reddy*, B. Srikanth
Organic Division - I, Indian Institute of Chemical Technology, Hyderabad 500007, India
Fax: +91(40)27160512; e-Mail: rajireddy@iict.res.in;
Further Information

Publication History

Received 6 March 2010
Publication Date:
10 May 2010 (online)

Abstract

The asymmetric synthesis of the tetrahydropyran containing C8-C20 fragment, a common key subunit of both (-)-dactyl­olide and (-)-zampanolide, is described. The salient feature of this synthesis is the extension of carbon chains using alkynols followed by the use of an alkyne system to generate the desired functionalities, in particular formation of the embedded pyran via an intramolecular oxa-Michael addition of a β-hydroxyynone.

    References and Notes

  • 1 Tanaka J. Higa T. Tetrahedron Lett.  1996,  37:  5535 
  • 2 Cutignano A. Bruno I. Bifulco G. Casapullo A. Debitus C. Gomez-Paloma L. Riccio R. Eur. J. Org. Chem.  2001,  775 
  • 3 Field JJ. Singh AJ. Kanakkaanthara A. Halafihi T. Northcote PT. Miller JH. J. Med. Chem.  2009,  52:  7328 
  • 4 Ding F. Jennings MP. J. Org. Chem.  2008,  73:  5965 
  • 5 Smith AB. Safonov IG. Corbett RM. J. Am. Chem. Soc.  2001,  123:  12426 
  • 6a Smith AB. Safonov IG. Corbett RM. J. Am. Chem. Soc.  2002,  124:  11102 
  • 6b Smith AB. Safonov IG. Org. Lett.  2002,  4:  635 
  • 6c Hoye TR. Hu M. J. Am. Chem. Soc.  2003,  125:  9576 
  • 6d Ding F. Jennings MP. Org. Lett.  2005,  7:  2321 
  • 6e Sanchez CC. Keck GE. Org. Lett.  2005,  7:  3053 
  • 6f Aubele DL. Wan S. Floreancig PE. Angew. Chem. Int. Ed.  2005,  44:  3485 
  • 6g Louis I. Hungerford NL. Humphries EJ. McLeod MD. Org. Lett.  2006,  8:  1117 
  • 6h Uenishi J. Iwamoto T. Tanaka J. Org. Lett.  2009,  11:  3262 
  • 6i Sharif E. O’Doherty GA. Chemtracts  2009,  22:  67 
  • 7a Loh T. Yang J. Feng L. Zhou Y. Tetrahedron Lett.  2002,  43:  7193 
  • 7b Troast DM. Yuan J. Porco JA. Adv. Synth. Catal.  2008,  1701 
  • 7c Smitha AB. Fox RJ. Razler TM. Acc. Chem. Res.  2008,  41:  675 
  • 8a Reddy CR. Rao NN. Tetrahedron Lett.  2009,  50:  2478 
  • 8b Reddy CR. Dharmapuri G. Rao NN. Org. Lett.  2009,  11:  5730 
  • 8c Reddy CR. Rao NN. Srikanth B. Eur. J. Org. Chem.  2010,  345 
  • 9 Shioiri T. McFarlane N. Hamada Y. Heterocycles  1998,  47:  73 
  • 10a Wang C. Forsyth CJ. Org. Lett.  2006,  8:  2997 
  • 10b Nicolaou KC. Cole KP. Frederick MO. Aversa RJ. Denton RM. Angew. Chem. Int. Ed.  2007,  46:  8875 
  • 10c Nicolaou KC. Frederick MO. Burtoloso ACB. Denton RM. Rivas F. Cole KP. Aversa RJ. Gibe R. Umezawa T. Suzuki T. J. Am. Chem. Soc.  2008,  130:  7466 
  • 11 Griggs ND. Phillips AJ. Org. Lett.  2008,  10:  4955 
  • 12 Yoshinari T. Ohmori K. Schrems MG. Pfaltz A. Suzuki K. Angew. Chem. Int. Ed.  2010,  49:  881 
13

Spectral Data for Representative Compounds
( S )-8-(Benzyloxy)-1-( tert -butyldiphenylsilyloxy)-2-hydroxyoct-5-yn-4-one (8)
[α]D ³¹ -8.5 (c 1.0, CHCl3). IR (KBr): νmax = 3442, 2929, 2215, 1670, 1426, 1110, 822, 703 cm. ¹H NMR (400 MHz, CDCl3): δ = 7.65-7.59 (m, 4 H), 7.43-7.21 (m, 11 H), 4.53 (s, 2 H), 4.25-4.16 (m, 1 H), 3.60 (t, J = 2.9 Hz, 2 H), 3.60 (td, J = 10.9, 5.1 Hz, 2 H), 2.74-2.71 (m, 2 H), 2.65 (t, J = 6.5 Hz, 2 H), 2.03 (br s, 1 H), 1.06 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 186.0, 137.6, 135.4, 132.9, 129.8, 128.4, 127.7, 127.6, 91.6, 81.4, 73.0, 68.0, 67.0, 66.8, 48.7, 26.8, 20.4, 19.1. ESI-HRMS: m/z calcd for C31H36NaO4Si: 523.2306 [M + Na]+; found: 523.2295.
(2 S ,6 S )-2-[2-(Benzyloxy)ethyl]-6-[( tert -butyldiphenyl-silyloxy)methyl]dihydro-2 H -pyran-4 (3 H )-one (10) [α]D ²7 -10 (c 1.0, CHCl3). IR (KBr): νmax = 2928, 2858, 1640, 1463, 1426, 1363, 1111, 701 cm. ¹H NMR (300 MHz, CDCl3): δ = 7.64 (td, J = 7.5, 1.3 Hz, 4 H), 7.44-7.17 (m, 11 H), 4.46 (AB, J = 12.2 Hz 1 H), 4.41 (AB, J = 12.2 Hz, 1 H), 3.83-3.49 (m, 6 H), 2.35 (dd, J = 14.1, 4.5 Hz, 3 H), 2.20 (ddd, J = 14.1, 11.5, 4.5 Hz, 1 H), 1.95-1.73 (m, 2 H), 1.02 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 207.3, 135.6, 135.5, 133.3, 133.2, 129.6, 128.3, 127.6, 127.5, 77.0, 73.9, 73.0, 66.3, 66.0, 47.7, 44.0, 36.4, 26.7, 19.2. ESI-HRMS: m/z calcd for C31H38NaO4Si: 525.2437 [M + Na]+; found: 525.2443.
( E )-6-[(2 S ,6 S )-6-Allyl-4-methylenetetrahydro-2 H -pyran-2-yl]-5-methylhex-5-en-2-yn-1-ol (16) [α]D ²8 -15.3 (c 0.5, CHCl3). IR (KBr): νmax = 3458, 2932, 2853, 2325, 1647, 1427, 1219, 1015, 893, 771 cm. ¹H NMR (300 MHz, CDCl3): δ = 5.91-5.74 (m, 1 H), 5.48 (dq, J = 7.1, 1.1 Hz, 1 H), 5.12-5.08 (m, 1 H), 5.08-5.01 (m, 1 H), 4.71 (t, J = 1.5 Hz, 2 H), 4.26 (s, 2 H), 4.00 (ddd, J = 10.9, 7.9, 2.8 Hz, 1 H), 3.41-3.30 (m, 1 H), 2.93 (s, 2 H), 2.45-2.32 (m, 1 H), 2.29-2.12 (m, 3 H), 2.06 (t, J = 12.8 Hz, 1 H), 1.93 (t, J = 12.8 Hz, 1 H), 1.58 (br s, 1 H), 1.75 (s, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 143.8, 134.0, 133.3, 126.4, 116.5, 108.3, 82.6, 80.4, 76.1, 75.1, 50.9, 40.2, 39.4, 29.2, 28.3, 16.4. ESI-HRMS: m/z calcd for C16H22NaO2: 269.1512 [M + Na]+; found: 269.151.
[(2 R ,3 R )-3-{( E )-3-[(2 S ,6 S )-6-Allyl-4-methylene-tetrahydro-2 H -pyran-2-yl]-2-methylallyl}oxiran-2-yl]-methanol (5)
[α]D ²7 -15.5 (c 1.0, CH2Cl2). IR (KBr): νmax = 3425, 3074, 2980, 2937, 2896, 1649, 1433 cm. ¹H NMR (300 MHz, CDCl3): δ = 5.92-5.70 (m, 1 H), 5.34 (dq, J = 7.7, 1.0 Hz, 1 H), 5.14-5.10 (m, 1 H), 5.09-5.02 (m, 1 H), 4.74 (t, J = 1.5 Hz, 2 H), 4.04 (ddd, J = 10.8, 7.7, 2.6 Hz, 1 H), 3.98-3.88 (m, 1 H), 3.71-3.60 (m, 1 H), 3.43-3.32 (m, 1 H), 3.07 (ddd, J = 5.6, 5.6, 2.2 Hz, 1 H), 2.97-2.93 (m, 1 H), 2.41 (dd, J = 14.1, 6.2 Hz, 1 H), 2.33 (dd, J = 14.5, 6.0 Hz, 1 H), 2.28-2.14 (m, 4 H), 2.05 (t, J = 12.6 Hz, 1 H), 1.93 (t, J = 12.6 Hz, 1 H), 1.76 (d, J = 1.1 Hz, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 144.2, 135.0, 134.4, 128.0, 116.9, 108.7, 77.7, 75.4, 61.4, 58.2, 54.5, 41.5, 40.7, 40.6, 39.8, 17.3. ESI-HRMS: m/z calcd for C16H24NaO3: 287.1618 [M + Na]+; found: 287.1626.